Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 280 clinical trials
Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

-Hodgkin lymphoma that has either come back or not responded to treatment. In this phase 1 study, different doses of ibrutinib (560 mg and 840 mg daily) will be tested to see what effect the drug has on

gilbert's syndrome
renal function
corticosteroids
hormonal therapy
stem cell transplantation
  • 41 views
  • 24 Jan, 2022
  • 2 locations
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

This is a research study to determine the safety and tolerability of ATLCAR.CD30 for treating relapsed/refractory Peripheral T Cell Lymphoma. Blood samples will be collected from study

cyclophosphamide
fludarabine
stem cell transplantation
hysterectomy
peripheral t-cell lymphoma
  • 0 views
  • 01 Jan, 2022
  • 2 locations
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma

Background The disease follicular lymphoma (FL) develops when the body makes abnormal B-cells. These cells usually build up in the lymph nodes, but can also affect

gilbert's syndrome
corticosteroids
oophorectomy
rituximab
platelet count
  • 84 views
  • 19 Jan, 2022
  • 1 location
RPTR-147 in Patients With Selected Solid Tumors and Lymphomas

and lymphomas.

advanced malignant solid tumor
solid tumor
lymphoma
ovarian cancer
lung cancer
  • 40 views
  • 29 Dec, 2021
  • 13 locations
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

> Eligibility Adults at least 18 years old who have metastatic solid tumors or lymphoma, which have progressed after other treatment. Design

tumor cells
chemotherapy regimen
nitrosoureas
bisphosphonate
lymphoma
  • 45 views
  • 26 Dec, 2021
  • 2 locations
A Study of Ruxolitinib and Duvelisib in People With Lymphoma

people with relapsed or refractory NK-cell or T-cell lymphoma.

t-cell leukemia
gilbert's syndrome
large cell lymphoma
leukemia
brentuximab
  • 0 views
  • 13 Jan, 2022
  • 7 locations
Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Phase 1 open label, multi-center, dose-escalation study for individuals with relapsed or refractory B-cell Non Hodgkin's Lymphoma.

measurable disease
bendamustine
lymphoma
b-cell lymphoma
refractory classical hodgkin lymphoma
  • 13 views
  • 19 Jan, 2022
  • 10 locations
NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma

Patients will receive intravenous (IV) NKTR-255 in 21 or 28 day treatment cycles. During the Part 1 dose escalation portion of the trial, patients will either receive NKTR-255 as monotherapy, NKTR-255 administered as a doublet with daratumumab subcutaneous (DARZALEX FASPRO TM), or NKTR-255 administered as a doublet with rituximab. After …

immunomodulatory imide drug
lymphoma
white blood cells
rituximab
neutrophil count
  • 5 views
  • 02 Jan, 2022
  • 35 locations
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Background Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the

chemotherapy regimen
granulocyte colony stimulating factor
lymphoma
filgrastim
oxygen saturation
  • 3 views
  • 15 Jan, 2022
  • 2 locations
SYMPHONY-2, A Trial to Examine Combination of Tazemetostat and Rituximab for Patients With Relapsed/Refractory Follicular Lymphoma

The goal of this study is to examine the feasibility and efficacy of adding the EZH2 inhibitor, tazemetostat, to rituximab, standard second line or beyond therapy as a means to improve disease response.

refractory follicular lymphoma
follicular lymphoma
rituximab
  • 0 views
  • 02 Jan, 2022
  • 8 locations